TOMM20 as a Potential Prognostic Biomarker in Chordoma: Results From a High-Volume, Single-Center Study.

Ida Micaily,Sherry Lee,Atrayee Basu Mallick,Tingting Zhan,Raymond O'Neill,Stacey Gargano,Bryan Hozack,Sameep Thapa,Ubaldo Martinez-Outschoorn,John Abraham,Wei Jiang

American journal of clinical pathology（2023）

引用 1|浏览8

暂无评分

摘要

Identifying novel signaling pathways that promote chordoma growth and recurrence is critical for developing targeted therapy for chordoma. TOMM20 may be a biomarker associated with chordoma disease progression.

查看译文

关键词

Chordoma,MCT1,Mitochondria,TIGAR,TOMM20

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要